A trial of OPA-15406 foam for eczema in children and infants
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a foam medication called OPA-15406 for children and infants with atopic dermatitis (eczema). It aims to see if the foam can help improve skin symptoms and is safe to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with atopic dermatitis (eczema) by a doctor using the Japanese Dermatological Association criteria.
- Your eczema should cover between 5% and 40% of your body surface area (not including the scalp) at both the first visit and a later check-up.
- Your eczema must have a severity score of 2 or 3 on a scale called IGA (Investigator's Global Assessment) at both the first visit and a later check-up.
- You must not have had a sudden worsening of your eczema or contact dermatitis in the 28 days before starting the study.
- You must not have used OPA-15406 ointment in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicated foam (OPA-15406) to see if it works better than a plain foam for adults with eczema. It might help reduce skin redness and itching.
This trial tests an experimental drug called SIM0278 for people with moderate to severe atopic dermatitis (eczema). It aims to see if the drug can reduce skin symptoms and is safe to use.
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
This study tests a new ointment called IN-115314 for adults with mild to moderate eczema. Researchers want to see if it helps control symptoms like itching and redness better than a placebo, and check that it's safe to use.
This trial tests a new gel called PG-011 for people with mild to moderate eczema (atopic dermatitis). The gel is applied to the skin, and the study will check if it helps improve symptoms safely.
Hear when a new Atopic Dermatitis (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.